Scientific Advisory Board

This widely respected group of medical and science professionals advises the Fund in all matters related to Fanconi anemia research. They help set research priorities, provide insight on the grants process, and contribute to the programming of the annual Fanconi Anemia Scientific Symposium. We are so grateful to have this dedicated group of doctors and researchers helping us to advance treatments and to find a cure for FA.

Blanche P. Alter

National Cancer Institute
Senior Clinician

Amy DeZern

Johns Hopkins
Assistant Professor of Oncology & Medicine, Dept. of Oncology; Attending Physician, Johns Hopkins Hospital

Jennifer Grandis

University of California, San Francisco
Professor in the Department of Otolaryngology – Head and Neck Surgery

Melissa Haendel

Oregon State University
Director of Translational Data Science, Linus Pauling Institute

Premal Patel

Lyell Immunopharma
Scientific Advisory Board Chair; Chief Medical Officer

Kathryn Pennington

University of Washington
Faculty Member in Gynecologic Oncology

Jeffrey Siegel

Genentech
Sr Group Medical Director, Product Development Immunology

Agata Smogorzewska

The Rockefeller University
Associate Professor

John Wagner

University of Minnesota
Professor, Dept. of Pediatrics; Pediatric Hematologist Oncologist